Literature DB >> 12401939

Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study.

Inge M van der Sluis1, Annemieke M Boot, Wim C Hop, Yolanda B De Rijke, Eric P Krenning, Sabine M P F de Muinck Keizer-Schrama.   

Abstract

AIM: To study the effects of growth hormone (GH) deficiency (GHD) and GH replacement therapy (GHRx) on bone mineral density (BMD) and body composition.
METHODS: 59 GHD children participated (age range 0.4-16.9 years); the follow-up period was 6 years. Lumbar spine BMD (BMD(LS)), total-body BMD (BMD(TB)), and body composition were measured prospectively using dual-energy X-ray absorptiometry.
RESULTS: Mean BMD(LS )and BMD(TB) were significantly reduced at the time of the diagnosis. The bone mineral apparent density of the lumbar spine (BMAD(LS)) was reduced to a lesser degree. The BMAD(LS) increased to normal values after 1 year; BMD(LS) and BMD(TB) normalized 1 year later. At the time of the diagnosis, the lean body mass was reduced and steadily increased during GHRx. Percentage of body fat was increased at baseline and normalized within 6 months. The severity of GHD was not associated with the BMD at diagnosis or the response to GHRx.
CONCLUSION: Areal BMD(LS) and BMD(TB) and, to a lesser extent, BMAD(LS) are decreased in GHD children, but normalize within 1-2 years. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401939     DOI: 10.1159/000066262

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  17 in total

1.  The effect of growth hormone deficiency on size-corrected bone mineral measures in pre-pubertal children.

Authors:  M Gahlot; R Khadgawat; R Ramot; M Eunice; A C Ammini; N Gupta; M Kalaivani
Journal:  Osteoporos Int       Date:  2011-11-10       Impact factor: 4.507

2.  Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in children treated for acute lymphoblastic leukaemia and growth hormone deficiency.

Authors:  Rick R van Rijn; Annemieke Boot; Rianne Wittenberg; Inge M van der Sluis; Marry M van den Heuvel-Eibrink; Maarten H Lequin; Sabine M P F de MuinckKeizer-Schrama; Cornelis Van Kuijk
Journal:  Pediatr Radiol       Date:  2006-01-24

Review 3.  Indications and strategies for continuing GH treatment during transition from late adolescence to early adulthood in patients with GH deficiency: the impact on bone mass.

Authors:  G Saggese; G I Baroncelli; T Vanacore; L Fiore; S Ruggieri; G Federico
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

4.  Long-term effects of growth hormone (GH) replacement therapy on hematopoiesis in a large cohort of children with GH deficiency.

Authors:  Andrea Esposito; Donatella Capalbo; Lucia De Martino; Martina Rezzuto; Raffaella Di Mase; Claudio Pignata; Mariacarolina Salerno
Journal:  Endocrine       Date:  2015-10-28       Impact factor: 3.633

5.  Risk factors for osteoporosis in long-term survivors of intracranial germ cell tumors.

Authors:  M J Kang; S M Kim; Y A Lee; C H Shin; S W Yang; J S Lim
Journal:  Osteoporos Int       Date:  2011-11-05       Impact factor: 4.507

6.  Effects of Growth Hormone Treatment on Lipid Profiles.

Authors:  Toshihide Kubo; Mahoko Furujo; Kyohei Takahashi; Yuki Hyodo; Hiroki Tsuchiya; Mariko Hattori; Shoko Fujinaga; Kenji Urayama
Journal:  Indian J Pediatr       Date:  2017-11-11       Impact factor: 1.967

Review 7.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

8.  Enhanced effect of zinc and calcium supplementation on bone status in growth hormone-deficient children treated with growth hormone: a pilot randomized controlled trial.

Authors:  Veena Ekbote; Anuradha Khadilkar; Shashi Chiplonkar; Zulf Mughal; Vaman Khadilkar
Journal:  Endocrine       Date:  2012-12-09       Impact factor: 3.633

9.  Measurement of body composition in burned children: is there a gold standard?

Authors:  Ludwik K Branski; William B Norbury; David N Herndon; David L Chinkes; Amalia Cochran; Oscar Suman; Deb Benjamin; Marc G Jeschke
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-11-02       Impact factor: 4.016

10.  Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.

Authors:  A Ciresi; G Pizzolanti; M Leotta; V Guarnotta; G Teresi; C Giordano
Journal:  J Endocrinol Invest       Date:  2016-04-28       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.